FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称DEUCRAVACITINIB
异名/同义词SOTYKTU
3-PYRIDAZINECARBOXAMIDE, 6-((CYCLOPROPYLCARBONYL)AMINO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)-
6-((CYCLOPROPYLCARBONYL)AMINO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(2H3)METHYL-3-PYRIDAZINE-CARBOXAMIDE
BMS-986165
DEUCRAVACITINIB
DEUCRAVACITINIB [INN]
DEUCRAVACITINIB [JAN]
DEUCRAVACITINIB [USAN]
DEUCRAVACITINIB [WHO-DD]
CAS登记号1609392-27-9
物质唯一标识(Unique Ingredient Identifier)N0A21N6RAU
分子式C20H22N8O3
国际化合物标识(International Chemical Identifier,InChI)BZZKEPGENYLQSC-FIBGUPNXSA-N
SMILESO(c1c(Nc2cc(NC(C3CC3)=O)nnc2C(=O)NC([2H])([2H])[2H])cccc1-c4nn(C)cn4)C
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 日本药品名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System